While all the studies showed a trend towards longer overall survival with nivolumab, statistical significance was only found in Lee et al.’s multivariate analysis ( 8 ).
← all excerpts
An Efficacy and Safety Comparison of Regorafenib and Nivolumab in Unresectable Hepatocellular Cancer Patients: A Systematic Review.
1
—
—